AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2018
Feb 21, 2018
29875_dirs_2018-02-21_ee3f1716-f1b7-4295-8fe5-c2140339ea2a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2018-02-16
Reporting Person: Foulkes Helena (EVP & President-CVS Pharmacy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-16 | Common Stock | M | 19965 | $45.07 | Acquired | 65072.3477 | Direct |
| 2018-02-16 | Common Stock | S | 19965 | $71.04 | Disposed | 45107.3477 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-16 | Stock Option | $45.07 | M | 19965 | Disposed | 2019-04-02 | Common Stock (19965) | Direct |
Footnotes
F1: Option became exercisable in four equal annual installments, commencing 4/2/2013.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3